This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for continuing Medical Education through the joint sponsorship of Medical Education Collaborative, Inc. (MEC) and Visionary Health Concepts.  MEC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Education Collaborative designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding the accreditation of this activity, please contact Medical Education Collaborative at (303) 420-3252.

Upon completion of this educational activity, participants should be able to:   

• Explain a rationale for the need for increased provider-patient communication about HIV drug resistance and testing

• Utilize simple language and low-literacy tools to update patients about HIV drug resistance and current changes in HIV guideline recommendations related to this topic

• Identify personal and situational patient factors (e.g., depression, stress, lower education) associated with uncertainty about the potential effectiveness of antiretroviral therapy and a patient’s perceived ability to adhere to therapy

The purpose of this activity is to provide clinicians with an effective educational program in a succinct and incremental format on the complex topic of viral resistance that takes into account the evolving nature of the science while providing clinically-relevant information.

The program is intended for physicians and healthcare providers treating HIV-positive patients, especially those who are seeking clinically-relevant and comprehensive information on viral resistance.

This activity is joint sponsored by Visionary Health Concepts and Medical Education Collaborative (MEC).  MEC is a non-profit organization

 that has been certifying quality educational activities since 1988.

Disclaimer: The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Medical Education Collaborative and Visionary Health Concepts. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Medical Education Collaborative and Visionary Health Concepts do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.  Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.

This activity was made possible by an educational grant from Boehringer Ingelheim.

Medical Education Collaborative adheres to ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education   In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, are made known below.

In this activity the faculty discloses they will not discuss the unlabeled use of or investigational use of any drugs, devices, procedures, or products.

CME Chairperson

Jonathan Schapiro, MD

Director HIV/AIDS, National Hemophelia Center, Israel

Adjunct Clinical Assistant Professor of Medicine (VCF)

Stanford University School of Medicine, Stanford, CA

Jonathan Schapiro, MD has the following relationships to disclose: speaker’s bureau, consultant, research support, advisory committee for Abbott Laboratories, Ambrilia, Bayer, Bristol Myers Squibb, Gilead, Merck, Monogram, Pfizer, Roche, Siemans and Tibotec Therapeutics.

Editor

Jacob Lalezari, MD

Medical Director

Quest Clinical Research

Assistant Clinical Professor of Medicine

University of California, San Francisco

Jacob Lalezari, MD has the following relationships to disclose: GlaxoSmithKline: clinical research support; Johnson & Johnson: clinical research support; Merck; clinical research support; Panacos: clinical research support; Pfizer: clinical research support, speakers’ bureau, consultant; Roche: clinical research support, speaker’s bureau, consultant; Tibotec Therapeutics: clinical research support.

Editor-in-Chief

            Lillian Thiemann

            President

            Visionary Health Concepts

            Lillian Thiemann has no relationships to disclose.

Writer          

           Kara Nyberg, PhD

           Science/Medical Writer

           Boulder, CO

           Kara Nyberg, PhD has no relationships to disclose.

Accredited Provider

          Employees of Medical Education Collaborative, the accredited provider for this activity, have

          disclosed that they have no significant financial relationships. 

Read the target audience, objectives, faculty disclosures and accreditation statements, then read the ResistanceWATCH News which is available in print or online, when finished reading all the content complete the  Post Test, credit application and evaluation which is found at the end of the printed program or online at www.freehivinfo.com. You must receive a test score of at least 75% and respond to all evaluation questions to receive a certificate. To receive your certificate, fax the post test, credit application and evaluation to Visionary Health Concepts FAX: 800-407-2505 or complete the forms online. NOTE: Participants who have successfully completed the online version of this activity are not eligible to receive credit for this print activity.

Medical Education Collaborative (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Medical Education Collaborative (MEC) and Visionary Health Concepts maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright^© Release Date: April 21, 2008 Expiration Date: April 21, 2009 Visionary Health Concepts.  All Rights Reserved.  Permission for accreditation use granted to Medical Education Collaborative (MEC).

 VHConcepts requires version 4.x browsers or higher from Microsoft or Netscape. This program is available online and as an Adobe Acrobat PDF document for easy download. To download a free copy of Acrobat Reader, please click here or visit http://www.adobe.com/products/acrobat/readstep2.html?promoid=BONRM